The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
JavaScript is disabled for your browser. Some features of this site may not work without it.
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
Dizdarevic, S.; Tulchinsky, M.; McCready, V.R.; Mihailovic, J,; Vinjamuri, S.; Buscombe, J.R.; Lee, S.T.; Frangos, S.; Sathekge, Mike Machaba; Siraj, Q.; Choudhury, P.; Bom, H.; Franceschi, M.; Ugrinska, A.; Paez, D.; Hussain, R.; Mailman, J.; Luster, M.; Virgolini, I.
The World Association of Radiopharmaceutical and Molecular
Therapy (WARMTH) is a worldwide nonprofit organization,
which is dedicated to educating medical professionals in
the use of radionuclide therapies based on the theragnostic
principles and to harmonizing appropriate evidence‑based
practices worldwide.